Global Immunoassays Market

An immunoassay is a test that relies on biochemistry to measure the presence and/or concentration of an analyte. The analyte can be large proteins, antibodies that a person has produced as a result of an infection or small molecules. According to the latest data, the market size of the global immunoassays sector is expected to rise by USD 11.6 billion with a CAGR of 5.7% by the end of 2029.

The report covers market size and growth, segmentation, regional breakdowns, competitive landscape, trends and strategies for global immunoassays market. It presents a quantitative analysis of the market to enable stakeholders to capitalize on the prevailing market opportunities. The report also identifies top segments for opportunities and strategies based on market trends and leading competitors’ approaches.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, technology, application, end user, and region. The global market for immunoassays can be segmented by product: analyzers, reagents & kits, software & services. Among these, the reagents & kits segment was accounted for the highest revenue generator in 2022. Immunoassays market is further segmented by technology: enzyme immunoassay (ELISA), chemiluminescent immunoassay (CLIA), fluorescent immunoassay (FIA), radioimmunoassay (RIA), lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA). The LFIA/MIA segment is estimated to account for the largest share of the global immunoassays market. Based on application, the immunoassays market is segmented into: cardiology, diabetes, drug screening, infectious diseases, oncology, reproductive, others. The infectious diseases segment held the largest share of the global immunoassays market in 2022 and is anticipated to hold its share during the forecast period. On the basis of end user, the immunoassays market also can be divided into: academia, blood banks, hospitals and clinincs, pharmaceutical & biotech companies, others. In 2022, the hospitals and clinincs segment made up the largest share of revenue generated by the immunoassays market. Immunoassays market by region is categorized into: Asia Pacific, Europe, North America, Rest of the World (RoW).

Market Segmentation
By product: analyzers, reagents & kits, software & services
By technology: enzyme immunoassay (ELISA), chemiluminescent immunoassay (CLIA), fluorescent immunoassay (FIA), radioimmunoassay (RIA), lateral flow immunoassay (LFIA)/multiplex immunoassay (MIA)
By application: cardiology, diabetes, drug screening, infectious diseases, oncology, reproductive, others
By end user: academia, blood banks, hospitals and clinincs, pharmaceutical & biotech companies, others
By region: Asia Pacific, Europe, North America, Rest of the World (RoW)

The report has also analysed the competitive landscape of the global immunoassays market with some of the key players being Abbott Laboratories, Abcam plc, Becton, Dickinson and Company, bioMerieux, S.A., Bio-Rad Laboratories, Inc., Danaher Corporation (Beckman Coulter Inc.), DiaSorin S.p.A., F. Hoffmann-La Roche AG, Merck & Co., Inc., Meril Life Sciences Pvt. Ltd., Mindray Medical International Limited, OraSure Technologies, Inc., Ortho Clinical Diagnostics Holdings plc, PerkinElmer, Inc., Quidel Corporation, Randox Laboratories Ltd., SD Biosensor, Inc., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific, Inc., among others. In this report, key players and their strategies are thoroughly analyzed to understand the competitive outlook of the market.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Scope of the Report
• To analyze and forecast the market size of the global immunoassays market.
• To classify and forecast the global immunoassays market based on product, technology, application, end user, region.
• To identify drivers and challenges for the global immunoassays market.
• To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global immunoassays market.
• To identify and analyze the profile of leading players operating in the global immunoassays market.

Why Choose This Report
• Gain a reliable outlook of the global immunoassays market forecasts from 2023 to 2029 across scenarios.
• Identify growth segments for investment.
• Stay ahead of competitors through company profiles and market data.
• The market estimate for ease of analysis across scenarios in Excel format.
• Strategy consulting and research support for three months.
• Print authentication provided for the single-user license.

Global Immunoassays Market

Interested in this report? Get your FREE sample now!
Global Immunoassays Market - Report Scope
REPORT ATTRIBUTE

DETAILS

Base Year

2022

Forecast Year

2023-2029

CAGR (2023-2029)

5.7%

Pages

91

Key Players

Abbott Laboratories, Abcam plc, Becton Dickinson and Company, bioMerieux S.A., Bio-Rad Laboratories Inc., Danaher Corporation (Beckman Coulter Inc.), DiaSorin S.p.A., F. Hoffmann-La Roche AG, Merck & Co. Inc., Meril Life Sciences Pvt. Ltd., Mindray Medical International Limited, OraSure Technologies Inc., Ortho Clinical Diagnostics Holdings plc, PerkinElmer Inc., Quidel Corporation, Randox Laboratories Ltd., SD Biosensor Inc., Siemens Healthineers AG, Sysmex Corporation, Thermo Fisher Scientific Inc.

Related Reports
Global Scar Management Market 2023

The global scar management market, in terms of revenue, is anticipated to progress at a CAGR of 5.8% during the forecast period, 2023-2029. Scar management encompasses various techniques and treatments…

READ MORE

$2,950.00

Want to customize this report?
The present report possesses the flexibility to be tailored to your specific needs. Our team of analysts and industry experts will collaborate directly with you to gain a comprehensive understanding of your requirements.
Scroll to Top

Download Free Sample - Global Immunoassays Market

Please fill out our form and we will get back to you.